These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29280473)

  • 1. The Safety of Low-Molecular-Weight Heparin During and After Pregnancy.
    Lu E; Shatzel JJ; Salati J; DeLoughery TG
    Obstet Gynecol Surv; 2017 Dec; 72(12):721-729. PubMed ID: 29280473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
    Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of venous thromboembolism in pregnant women with essential thrombocythemia: a systematic review and meta-analysis.
    Skeith L; Carrier M; Robinson SE; Alimam S; Rodger MA
    Blood; 2017 Feb; 129(8):934-939. PubMed ID: 28049641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses.
    Bleker SM; Buchmüller A; Chauleur C; Ní Áinle F; Donnelly J; Verhamme P; Jacobsen AF; Ganzevoort W; Prins M; Beyer-Westendorf J; DeSancho M; Konstantinides S; Pabinger I; Rodger M; Decousus H; Middeldorp S
    Thromb Res; 2016 Aug; 144():62-8. PubMed ID: 27289488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence and risk factors of recurrent venous thromboembolism during pregnancy.
    Galambosi PJ; Ulander VM; Kaaja RJ
    Thromb Res; 2014 Aug; 134(2):240-5. PubMed ID: 24835671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thromboprophylaxis with low-molecular-weight heparin insufficient in high-risk pregnancy].
    Roeters van Lennep JE; Meijer E; Klumper FJ; Middeldorp JM; Bloemenkamp KW; Middeldorp S
    Ned Tijdschr Geneeskd; 2011; 155():A3433. PubMed ID: 21527059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and management of venous thromboembolism in pregnancy: cutting through the practice variation.
    Skeith L
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):559-569. PubMed ID: 34889418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis with low-dose low-molecular-weight heparin during pregnancy and postpartum: is it effective?
    Roeters van Lennep JE; Meijer E; Klumper FJ; Middeldorp JM; Bloemenkamp KW; Middeldorp S
    J Thromb Haemost; 2011 Mar; 9(3):473-80. PubMed ID: 21232006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the Delphi method to facilitate antithrombotics prescription during pregnancy.
    Chauleur C; Gris JC; Laporte S; Rancon F; Varlet MN; Decousus H; Mismetti P;
    Thromb Res; 2010 Aug; 126(2):88-92. PubMed ID: 20153880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women's values and preferences and health state valuations for thromboprophylaxis during pregnancy: A cross-sectional interview.
    Bates SM; Alonso-Coello P; Tikkinen KA; Ebrahim S; Lopes LC; McDonald SD; Zhou Q; Akl EA; Neumann I; Jacobsen AF; Zhang Y; Santamaría A; Annichino-Bizzacchi JM; Sandset PM; Bitar W; Eckman MH; Guyatt GH
    Thromb Res; 2016 Apr; 140():22-9. PubMed ID: 27500301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight-adjusted LMWH prophylaxis provides more effective thrombin inhibition in morbidly obese pregnant women.
    Ismail SK; Norris L; O'Shea S; Higgins JR
    Thromb Res; 2014 Aug; 134(2):234-9. PubMed ID: 24984985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevention of pregnancy-related venous thromboembolism.
    Guimicheva B; Czuprynska J; Arya R
    Br J Haematol; 2015 Jan; 168(2):163-74. PubMed ID: 25312482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Continuation of Low-Molecular-Weight Heparin versus Switching to Unfractionated Heparin in the Peripartum.
    Enakpene CA; Pontarelli KN; Della Torre M
    Am J Perinatol; 2020 Feb; 37(3):304-312. PubMed ID: 30818404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of postpartum hemorrhage in women using high dose of low-molecular-weight heparins during pregnancy.
    Knol HM; Schultinge L; Veeger NJ; Kluin-Nelemans HC; Erwich JJ; Meijer K
    Thromb Res; 2012 Sep; 130(3):334-8. PubMed ID: 22475315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-molecular-weight heparin in pregnancy: peripartum bleeding complications.
    Kominiarek MA; Angelopoulos SM; Shapiro NL; Studee L; Nutescu EA; Hibbard JU
    J Perinatol; 2007 Jun; 27(6):329-34. PubMed ID: 17443203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Multicentre Study of Thromboprophylaxis in Pregnancy.
    Crowley MP; Noone C; Higgins JR; O'Shea S
    Ir Med J; 2017 May; 110(5):567. PubMed ID: 28737308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of low molecular weight heparin in pregnant women with mechanical heart valves.
    Yinon Y; Siu SC; Warshafsky C; Maxwell C; McLeod A; Colman JM; Sermer M; Silversides CK
    Am J Cardiol; 2009 Nov; 104(9):1259-63. PubMed ID: 19840573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy-associated venous thromboembolism: prevention and treatment.
    Bates SM
    Semin Hematol; 2011 Oct; 48(4):271-84. PubMed ID: 22000093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Xa Monitoring of Low-Molecular-Weight Heparin during Pregnancy: A Systematic Review.
    Kjaergaard AB; Fuglsang J; Hvas AM
    Semin Thromb Hemost; 2021 Oct; 47(7):824-842. PubMed ID: 34130342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism in pregnancy: prophylaxis and treatment with low molecular weight heparin.
    Andersen AS; Berthelsen JG; Bergholt T
    Acta Obstet Gynecol Scand; 2010; 89(1):15-21. PubMed ID: 19916891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.